Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Implant may prevent spread of cancer
Microscope
Scientists are planning the first clinical trials in humans very soon.
Device sucks up cancer cells as they move through the body

A tiny implant that sucks up cancer cells as they move through the body has been developed by scientists in the USA.

Although the device has only been tested in mice with breast cancer, scientists hope that it may one day alert doctors to the spread of cancer, acting as an early warning system for human patients.

The findings, published in Nature Communications, show that the implant could also prevent rogue cancer cells reaching other areas where new tumours could develop.

The device is around 5mm in diameter and is made of a sponge-like material that is already approved for use in medicine.

Experiments showed that if the device was planted under the skin or in the abdominal fat, it would mop up the cancer cells that had begun to move around the body.

Study leader Professor Lonnie Shea, from the Department of Biomedical Engineering at the University of Michigan, told the BBC that they were planning the first clinical trials in humans fairly soon.

"We need to see if metastatic cells will show up in the implant in humans like they did in the mice, and also if it's a safe procedure and that we can use the same imaging to detect cancer cells," he said.

Cancer Research say that nine out of 10 cancer deaths are caused by the spread of the disease to other parts of the body.

Lucy Holmes, Cancer Research UK's science information manager, added: "We urgently need new ways to stop cancer in its tracks.

"So far this implant approach has only been tested in mice, but it's encouraging to see these results, which could one day play a role in stopping cancer spread in patients."

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.